Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
A report from the British Broadcasting Corporation this morning says, “Scientists found that in patients with prostate cancer exosomes contain molecules that come directly from the tumour itself.” These particular “exosomes” are fatty capsules that are flushed out of the body in the urine.
Filed under: Diagnosis, Risk | Tagged: exosomes, risk, test, urine | Leave a Comment »
A group of investigators is conducting an online survey of the knowledge of patients, friends, and family members about cancers of the reproductive system and their treatment, including prostate cancer. Your sitemaster has already completed the survey, was able to do it in about 12 minutes, and admits to not knowing the answers to some [...]
Filed under: Uncategorized | Leave a Comment »
In March this year we reported briefly on an article by Van Poppel et al. reviewing available data on the adjuvant and the delayed use of hormone therapy in the treatment of prostate cancer and the related issue of PSA recurrence (particularly in high risk patients).
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adjuvant, ADT, androgen deprivation therapy, delayed, immediate | Leave a Comment »
According to a new report just published in the Annals of Family Medicine and summarized on Bloomberg.com, 36.7 percent of men and 26.2 percent of women who have recommended cancer screening tests for three of four different cancers will be given false positive results by the time they have undergone just four of the 14 [...]
Filed under: Diagnosis, Risk | 1 Comment »
Today’s news reports cover items on: The feasibility of gene expression analysis and prostate cancer prognosis The potential of color Döppler ultrasound to assess prostate cancer risk Radical perineal prostatectomy and quality of life in Japanese patients Outcomes and satisfaction with treatment among patients < 65 years of age LHRH agonist therapy and cognitive dysfunction
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: cognitive dysfunction, color Döppler ultrasound, gene expression, Japanese, LHRH agonist, outcome, perineal prostatectomy, prognosis, risk, satisfaction | Leave a Comment »
In April this year, the Prostate Cancer Foundation coordinated a media roundtable meeting at the National Press Club in Washington, DC, to address priorities on the prostate cancer research front and related issues. The “New” Prostate Cancer InfoLink is pleased to see that the full transcript of this meeting is now available. You can also [...]
Filed under: Uncategorized | Comments Off
Now after you have read this, we do not think you should be rushing out to fill your medicine cabinet with vitamin A. We need more research to validate the results of this study, but …
Filed under: Prevention | Tagged: aggressive, Prevention, vitamin A | 2 Comments »
Prostate Cancer International collaborated earlier today with the Prostate Cancer Mission at the Mission’s second “open conversation” about prostate cancer at Florida International University in north Miami, Florida.
Filed under: About Us | Tagged: Open Conversation, Prostate Cancer Mission | Leave a Comment »
This morning’s news reports discuss: Vasectomy and prostate cancer Preservation of erectile function during radical prostatectomy Interferon-alfa as a treatment for localized prostate cancer Immunotherapeutic agents in treatment of prostate cancer
Filed under: Diagnosis, Drugs in development, Management, Risk, Treatment | Tagged: erectile function, immunotherapy, interferon, vasectomy | Leave a Comment »
In today’s news reports we address such issues as: The possibility that type of initial treatment and comorbidities explain at least some racial disparities in prostate cancer survival Failure of time to surgery to explain racial disparities in post-treatment outcome Once-weekly bicalutamide as a regimen to prevent prostate cancer
Filed under: Management, Prevention, Treatment, Uncategorized | Tagged: bicalutamide, mortality, outcome, racial disparities, weekly | Leave a Comment »
Prostate stem cell antigen (PSCA) is a cell surface antigen found in normal human prostate tissue and over-expressed in men who have prostate cancer.
Filed under: Drugs in development, Living with Prostate Cancer | Tagged: immunotherapy, pmPSCA, vaccine | Leave a Comment »
Today’s prostate cancer news reports address articles on: The role of MRI in prostate cancer diagnosis The accuracy of different types of MR imaging Removal of the seminal vesicles in surgical treatment of low-risk disease Current treatment strategies for advanced prostate cancer
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: advanced, low risk, magnetic resonance imaging, MRI, seminal vesicles, surgery | Leave a Comment »
According to a media release from Eli Lilly and Company late yesterday, a double-blind, placebo-controlled study has shown that tadalafil (Cialis) 5 mg taken once daily improved erectile function for men with erectile dysfunction (ED) and reported improvement in the sexual quality of life scores for men and their female partners.
Filed under: Living with Prostate Cancer | Tagged: erectile dysfunction, partner, sexual quality of life, tadalafil | 2 Comments »
In today’s new items we identified items dealing with: New learnings about radical prostatectomy Heated gold nanoparticles as treatment for solid tumors A three-drug chemotherapy combination for HRPC
Filed under: Drugs in development, Management, Treatment | Tagged: docetaxel, estramustine, gold, HRPC, nanoparticles, radical prostatectomy, vinorelbine | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site